OBJECTIVE: To evaluate the outcome of pregnancy after uterine fibroid embolization (UFE). DESIGN: Retrospective study. SETTING: Private hospital affiliated with a university. PATIENT(S): In a single center, UFE was performed in 74 patients who wanted to become pregnant. INTERVENTION(S): Polyvinyl alcohol particles (PVA) or embozene microspheres were used to embolize the uterine arteries. Enhanced pelvic magnetic resonance was performed before UFE and 6 months after UFE in all patients. MAIN OUTCOME MEASURE(S): The number of pregnancies and their development. RESULT(S): Of the 74 women who wanted to become pregnant, 44 of them became pregnant (59.5%). There are five (11.3%) ongoing pregnancies and 39 (88.7%) finished pregnancies, with 33 successful live births (84.6%), four spontaneous abortions (10.3%), one induced abortion, and one stillbirth. There were 22 cesarean deliveries (66.6%), two preterm deliveries at 36 weeks (6.1%), and five low birth weights. CONCLUSION(S): Pregnancy after UFE appears to be safe.
OBJECTIVE: To evaluate the outcome of pregnancy after uterine fibroid embolization (UFE). DESIGN: Retrospective study. SETTING: Private hospital affiliated with a university. PATIENT(S): In a single center, UFE was performed in 74 patients who wanted to become pregnant. INTERVENTION(S): Polyvinyl alcohol particles (PVA) or embozene microspheres were used to embolize the uterine arteries. Enhanced pelvic magnetic resonance was performed before UFE and 6 months after UFE in all patients. MAIN OUTCOME MEASURE(S): The number of pregnancies and their development. RESULT(S): Of the 74 women who wanted to become pregnant, 44 of them became pregnant (59.5%). There are five (11.3%) ongoing pregnancies and 39 (88.7%) finished pregnancies, with 33 successful live births (84.6%), four spontaneous abortions (10.3%), one induced abortion, and one stillbirth. There were 22 cesarean deliveries (66.6%), two preterm deliveries at 36 weeks (6.1%), and five low birth weights. CONCLUSION(S): Pregnancy after UFE appears to be safe.